1-1 of 1
Philip Y. Dien
Close
Sort by
Journal Articles

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma

Clinical Trials & Observations
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran, Jr, Philip Y. Dien, Roger Lyons, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, Lina Asmar
Journal: Blood
Blood (2010) 115 (3): 475–480.
https://doi.org/10.1182/blood-2009-08-233155
Published: 2010